At BioMeca, based in Lyon, France, we specialize in revealing how biological tissues respond to mechanical forces. Our mission is to provide cosmetic innovators, pharmaceutical leaders, and researchers with advanced tools to better understand the skin—from its surface down to the deepest compartments.
Our flagship technology, EASYSTIFF, is dedicated to in vivo applications. It measures the biomechanical properties of human skin directly, with a unique indentation-based method. This non-invasive approach allows precise monitoring of stiffness, elasticity, and product penetration over time, offering unparalleled insights into aging, regeneration, and treatment efficiency in living tissue.
In parallel, BioMeca® develops high-resolution in vitro and ex vivo studies using atomic force microscopy (AFM) and complementary imaging techniques. AFM provides nanoscale insights into tissue sections, explants, or cell cultures, enabling us to investigate the basement membrane, collagen networks, and cellular mechanics. These approaches bridge molecular details with macroscopic functions, giving a complete picture of skin remodeling processes.
What sets BioMeca apart is the synergy between these scales of analysis: from in vivo monitoring with EASYSTIFF, to ex vivo and in vitro exploration with AFM. This integration delivers comprehensive knowledge of skin mechanics, making us a trusted partner for projects ranging from dermo-cosmetic testing to biomedical innovation.
By linking structure, function, and clinical relevance, BioMeca® helps researchers and industry leaders turn scientific questions into actionable answers. Our unique expertise makes visible what no one else can see: the subtle mechanical language of tissues.
Advertorial
CONTACT
JULIEN CHLASTA
CEO
julien.chlasta@bio-meca.com /
Discover their latest services during the exclusive webinar and the latest evaluation trends and innovations in preclinical trials and clinical studies.
